Abstract Details

Title Real World Comparison of Patient Adherence and Persistence to Fingolimod vs. Dimethyl Fumarate

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 101

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
John Ko, PharmD, MS (Alnylam)	Dr. Ko has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Ko has received personal compensation for serving as an employee of Novartis. Dr. Ko has received stock or an ownership interest from Alnylam Pharmaceuticals. Dr. Ko has received stock or an ownership interest from Novartis.
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ����